Company profile image

Serenus.AI

National flag images

Israel

Founded in

15 Mar 2017 (8 Years)

Founded

Last online: No recent activity


No Review

Not enough to calculate score

Verification on TrustFinance icon

Verification on TrustFinance

0.00

Traffic & Engagement icon

Traffic & Engagement

1.67

This company no score yet, be the first to review

Trustfinance icon

Provided by TrustFinance

A

AFDA B.V.

no review

N/A

N/A

Security Information :

Company hasn't provided information.

Security Information

    Note icon

    What are the differences in regulations for each

    License

    A Grade License

    Issued by globally renowned regulators, these licenses ensure the highest trader protection through strict compliance, fund segregation, insurance, and regular audits. Dispute resolution and adherence to AML/CTF standards further enhance security.

    B Grade License

    Granted by respected regional regulators, these licenses offer robust safety measures such as fund segregation, financial reporting, and compensation schemes. Though slightly less strict than Tier 1, they provide dependable regional protection.

    C Grade License

    Issued by regulators in emerging markets, these licenses offer basic protections such as minimum capital requirements and AML policies. Oversight is less stringent, so traders should exercise caution and verify safety measures.

    D Grade License

    From jurisdictions with minimal oversight, these licenses often lack key protections like fund segregation and insurance. While attractive for operational flexibility, they pose higher risks to traders.

    building-icon

    Company Information

    Get to know Serenus.AI

    Serenus.AI has a strong passion to improve healthcare delivery and patients' outcome. Its unique patented technology was developed to improve medical treatment decisions, saving lives, and valuable resources. Among the Serenus.AI team are top medical experts from various medical fields and machine learning specialists. The innovative solution was already validated in practice and the company is currently active in Europe and the US with leading stakeholders in the healthcare field. The company received grants from 4 government entities in Israel who validated its innovation and technology, including the Ministry of Health, Ministry of Economics, the Innovation Authority, and the Bilateral US-Israel Bird Award. Please also see articles about our solution: https://www.extra-mag.co.il/making-an-informed-decision/ https://www.yorkshireeveningpost.co.uk/health/can-smart-robot-match-surgeons-skills-leeds-researchers-will-find-out-2005357 https://datarootlabs.com/blog/ai-in-healthcare-how-ai-startups-disrupt-the-healthcare-industry Hillary Orly Harel | CEO and Co-Founder of Serenus.AI:  Winner | Winner of Department for International Trade (DIT)'s first-ever "2020 European Women in Tech"  Finalist | Winner of Quesnay's Female Founders in InsurTech 2020"   Named | Winner of Top AI start-up company in "Healthcare Innovation Landscape 2020"  Data Roots Labs report Named | Winner of 58th Most Influential Woman in the Tech World

    Industry

    • Financial InsurancePRIMARY

    Contact

    location-contact-icon

    -

    website-contact-icon

    -

    phone-contact-icon

    -

    email-contact-icon

    -

    Social

    Company hasn't updated its information.

    Social scout image

    Social Scout

    See what Social Scout found of Serenus.AI

    Trustfinance icon

    Provided by TrustFinance AI Analysis

    Reviews

    Total 0

    Review analysis image

    AI Review analysis

    Let’s TrustFinance AI Summarize all the reviews for you.

    Trustfinance icon

    Provided by TrustFinance AI Analysis

    Filter

    5 Star

    0%

    4 Star

    0%

    3 Star

    0%

    2 Star

    0%

    1 Star

    0%

    Sort by